Here, we report conserved colon length and weight change in IBD mouse models treated with Tnf−/− macrophages, and IMC analysis reveals increased transit-amplifying cells closely associated with a specific fibroblast population, indicating mechanistic insight of macrophage cell therapy for IBDs. This evidence concerns the gene TNF and inflammatory bowel disease.